Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

153.58 +6.14 (+4.16%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,784,561
Open 148.52
Bid (Size) 153.40 (1)
Ask (Size) 153.87 (1)
Prev. Close 147.44
Today's Range 147.89 - 154.98
52wk Range 115.03 - 217.25
Shares Outstanding 385,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Could This Move by Johnson & Johnson Equal Billions for Moderna?
An RSV vaccine could be a driver of blockbuster revenue. 
Via The Motley Fool
COVID Remains A Global Threat – NanoViricides Set To Begin Clinical Trials For Pan-Coronavirus Drug To Help Defeat COVID Once And For All
Effective treatments for COVID-19 remain very few and very limited in their capabilities, even after three years. As a result, there are still high rates of hospitalizations and COVID remains many... 
Via Benzinga

Performance

YTD
-14.20%
-14.20%
1 Month
+11.40%
+11.40%
3 Month
-14.20%
-14.20%
6 Month
+26.94%
+26.94%
1 Year
-13.03%
-13.03%

More News

Read More
11 Stocks: 9 Dividend Payers 2 For Growth
Via Talk Markets
Moderna Finalizes Agreement with the Government of the Republic of Kenya to Establish an mRNA Manufacturing Facility
Via ACCESSWIRE
J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out
Via Investor's Business Daily
Check Out What Whales Are Doing With MRNA
Via Benzinga
Looking At Moderna's Recent Unusual Options Activity
Via Benzinga
3 Things About Moderna That Smart Investors Know
Via The Motley Fool
(MRNA) - Analyzing Moderna's Short Interest
Via Benzinga
Moderna's CEO Just Gave Investors a Huge Reason to Sell the Stock
Via The Motley Fool
The Ultimate Growth Stock to Buy With $150 Right Now
Via The Motley Fool
2 Nasdaq 100 Stocks to Buy Hand Over Fist Right Now
Via The Motley Fool
Could CRISPR Therapeutics Become the Next Moderna?
Via The Motley Fool
Moderna to Host Fourth Annual Virtual Vaccines Day on April 11, 2023
Via ACCESSWIRE
Why Generation Bio Shares Are Trading Higher Today
Via Benzinga
Moderna, Generation Bio Collaborate To Develop Non-Viral Genetic Medicines
Via Benzinga
Check Out What Whales Are Doing With MRNA
Via Benzinga
7 Blue-Chip Stocks Sitting in the Sweet Spot
Via InvestorPlace
Apple Jumps Movie Production Bandwagon, Billionaire Jim Ratcliffe Bids For Manchester United, Elon Musk Seeks Funding For SpaceX From Middle-Eastern Fund: Today's Top Stories
Via Benzinga
Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines
Via ACCESSWIRE
Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines
From Generation Bio Co.; Moderna
Via Globe NewsWire
China's First mRNA Vaccine: Drugmaker CSPC Wins China's Approval For COVID-19 Vaccine
Via Benzinga
Additional COVID-19 Booster Shots? Officials Anticipate FDA Authorization Within Few Weeks
Via Benzinga
If You Invested $5,000 in Moderna in 2020, This Is How Much You Would Have Today
Via The Motley Fool
Covid Vaccine Battle Brewing: Moderna's Stephane Bancel Vs. Bernie Sanders
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.